JPWO2022221479A5 - - Google Patents

Download PDF

Info

Publication number
JPWO2022221479A5
JPWO2022221479A5 JP2023563176A JP2023563176A JPWO2022221479A5 JP WO2022221479 A5 JPWO2022221479 A5 JP WO2022221479A5 JP 2023563176 A JP2023563176 A JP 2023563176A JP 2023563176 A JP2023563176 A JP 2023563176A JP WO2022221479 A5 JPWO2022221479 A5 JP WO2022221479A5
Authority
JP
Japan
Prior art keywords
hla
cell
optionally
magec2
peptide
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2023563176A
Other languages
English (en)
Japanese (ja)
Other versions
JP2024515646A5 (https=
JP2024515646A (ja
Publication date
Application filed filed Critical
Priority claimed from PCT/US2022/024728 external-priority patent/WO2022221479A2/en
Publication of JP2024515646A publication Critical patent/JP2024515646A/ja
Publication of JPWO2022221479A5 publication Critical patent/JPWO2022221479A5/ja
Publication of JP2024515646A5 publication Critical patent/JP2024515646A5/ja
Pending legal-status Critical Current

Links

JP2023563176A 2021-04-14 2022-04-14 Ｍａｇｅｃ２免疫原性ペプチド、ｍａｇｅｃ２免疫原性ペプチドを認識する結合性タンパク質、及びその使用 Pending JP2024515646A (ja)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US202163174808P 2021-04-14 2021-04-14
US63/174,808 2021-04-14
US202263329523P 2022-04-11 2022-04-11
US63/329,523 2022-04-11
PCT/US2022/024728 WO2022221479A2 (en) 2021-04-14 2022-04-14 Magec2 immunogenic peptides, binding proteins recognizing magec2 immunogenic peptides, and uses thereof

Publications (3)

Publication Number Publication Date
JP2024515646A JP2024515646A (ja) 2024-04-10
JPWO2022221479A5 true JPWO2022221479A5 (https=) 2025-04-21
JP2024515646A5 JP2024515646A5 (https=) 2025-04-21

Family

ID=83641016

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2023563176A Pending JP2024515646A (ja) 2021-04-14 2022-04-14 Ｍａｇｅｃ２免疫原性ペプチド、ｍａｇｅｃ２免疫原性ペプチドを認識する結合性タンパク質、及びその使用

Country Status (11)

Country Link
US (1) US20240190931A1 (https=)
EP (1) EP4323379A4 (https=)
JP (1) JP2024515646A (https=)
KR (1) KR20240007162A (https=)
AU (1) AU2022256469A1 (https=)
BR (1) BR112023021162A2 (https=)
CA (1) CA3216553A1 (https=)
IL (1) IL307601A (https=)
MX (1) MX2023012141A (https=)
TW (1) TW202304964A (https=)
WO (1) WO2022221479A2 (https=)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN117820429B (zh) * 2024-01-11 2024-06-18 中国水产科学研究院南海水产研究所 一种具有inos抑制作用的乌鳢源活性肽
AU2025202443A1 (en) * 2024-04-08 2025-10-23 Tscan Therapeutics, Inc. Magec2 immunogenic peptides, binding proteins recognizing magec2 immunogenic peptides, and uses thereof
CN120098931A (zh) * 2025-02-10 2025-06-06 武建强 具有杀伤和肿瘤抑制功效的tcr-t细胞及其应用

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP5292550B2 (ja) * 2007-03-23 2013-09-18 静岡県 Ｔ細胞レセプターβ鎖遺伝子及びα鎖遺伝子
ES2635335T3 (es) * 2010-09-20 2017-10-03 Biontech Cell & Gene Therapies Gmbh Receptores de células T específicos de antígeno y epítopos de células T
US9205144B2 (en) * 2011-06-03 2015-12-08 Dana-Farber Cancer Institute, Inc. Identification of conserved peptide blocks in homologous polypeptides
GB201520539D0 (en) * 2015-11-23 2016-01-06 Immunocore Ltd & Adaptimmune Ltd Peptides
CN119930795A (zh) * 2017-10-12 2025-05-06 得克萨斯大学体系董事会 用于免疫疗法的t细胞受体
CN109776671B (zh) * 2017-11-14 2022-05-27 杭州康万达医药科技有限公司 分离的t细胞受体、其修饰的细胞、编码核酸、表达载体、制备方法、药物组合物和应用
US20210061914A1 (en) * 2017-12-28 2021-03-04 Gritstone Oncology, Inc. Antigen-Binding Proteins Targeting Shared Antigens
CN112004825A (zh) * 2018-02-12 2020-11-27 弗雷德哈钦森癌症研究中心 细胞周期蛋白a1特异性t细胞受体及其用途
CN112368386A (zh) * 2018-05-23 2021-02-12 磨石肿瘤生物技术公司 共有抗原
CN112888707B (zh) * 2018-08-16 2025-04-25 百欧恩泰美国公司 T细胞受体构建体及其用途
GB201814362D0 (en) * 2018-09-04 2018-10-17 Treos Bio Zrt Composition and process for preparing vaccine
SG11202103609YA (en) * 2018-10-25 2021-05-28 Council Queensland Inst Medical Res T-cell receptors and uses thereof
EP3917542A4 (en) * 2019-01-29 2023-03-08 Gritstone bio, Inc. MULTISPECIFIC BINDING PROTEINS

Similar Documents

Publication Publication Date Title
JP7270001B2 (ja) Ｍｈｃクラスｉｉ拘束性ｍａｇｅ－ａ３を認識するｔ細胞受容体
CN112979783B (zh) 获得肿瘤特异性t细胞受体的方法
CN110785432B (zh) Tcr和肽
CN106068276B (zh) 具有针对T细胞受体beta恒定区的抗原结合域的嵌合抗原受体(CAR)
JP7635165B2 (ja) ｐ５３におけるＲ１７５Ｈ又はＹ２２０Ｃ変異を認識するＴ細胞受容体
JP2023534808A (ja) 養子細胞療法のための標的共刺激を提供する受容体
US12275786B2 (en) Anti-thyroglobulin t cell receptors
US20220064257A1 (en) Specific t cell receptors against epitopes of mutant myd88l265p protein for adoptive t cell therapy
EP3731861A1 (en) T cell receptors for tumor specific proteasome splice variants and uses thereof
Hill et al. Early‐onset myasthenia gravis: A recurring T‐cell epitope in the adult‐specific acetylcholine receptor ε subunit presented by the susceptibility allele HLA‐DR52a
CA2894966A1 (en) Novel mhc-independent tumor-associated antigens
Nakatsugawa et al. CD4+ and CD8+ TCRβ repertoires possess different potentials to generate extraordinarily high-avidity T cells
JPWO2022221479A5 (https=)
JPWO2023086480A5 (https=)
JP2025518203A (ja) Ｍａｇｅ－ａ１特異的ｔｃｒ及びその用途
JPWO2022221478A5 (https=)
JPWO2022099100A5 (https=)
US20250122302A1 (en) Antigen binding proteins specifically binding ct45
EP4223782A1 (en) Novel t cell receptors and immune therapy using the same for the treatment of cancer
JP2007097580A (ja) Ｔ細胞レセプターβ鎖遺伝子
Hess et al. Functionally divergent T lymphocyte responses induced by modification of a self-peptide from a tumor-associated antigen
Wei Engineering HLA-I molecules for improved anti-tumor T cell response for cancer immunotherapy
NL2021034B1 (en) TEIPP neoantigens and uses thereof
JPWO2022104002A5 (https=)
NL2021037B1 (en) TEIPP neoantigens and uses thereof